NR 606 Week 5 Study Guide 2025: Neurological & Musculoskeletal Diagnosis in Primary Care

Page 1 of 60


NR606 / NR606 / NR 606 Week 5 (Latest Update 2025):

Diagnosis & Management in Psychiatric-Mental Health

II Practicum | Complete Guide with Questions and

Verified Answers | 100% Correct - Chamberlain

(Latest Update 2025): Diagnosis & Management in

Psychiatric-Mental Health II Practicum | Complete

Guide with Questions and Verified Answers | 100%

Correct - Chamberlain

Stimulant Medications: Methylphenidate .....ANSWER.....-Low risk

of adverse effects

-Available formulations:

• Ritalin - available in immediate release (IR) and extended

release (XR) available in beads that may be sprinkled on food

for children who cannot swallow pills

,Page 2 of 60


• Concerta biphasic - combined immediate and delayed release

in one medication

• Daytrana - patch applied in AM and removed after 9 hour

Stimulant Medications: Dexmethylphenidate (Focalin)

.....ANSWER.....-Available in IR and ER

-More potent than Ritalin

-High risk of adverse effects

Stimulant Medications: Amphetamine (Adzenys) .....ANSWER.....-

available in orally disintegrating ER formula for children who

cannot swallow pills

-Avoid prescribing when an MAOI has been used within 14 days

Stimulant Medications: Dextroamphetamine (Adderall)

.....ANSWER.....-Available in IR and extended-release

formulations

,Page 3 of 60


-Often dosed in morning (IR or XR) with an evening or evening

prn (IR) dose if med effects diminish prior to end of school, study

or the workday

-Most abused & diverted prescription stimulant

Stimulant Medications: Lisdexamfetamine (Vyvanse)

.....ANSWER.....-Biologically inactive until metabolized by the

body (Prodrug)

-Less abuse & diversion potential than other stimulants

-Higher-cost medication

Non-stimulant medication: Atomoxetine (Strattera)

.....ANSWER.....-Noradrenergic (NRI)

-Initial drug of choice for adults with ADHD

-no abuse potential

-tolerated well when prescribed in BID dosing

-appropriate choice for comorbid substance abuse

, Page 4 of 60


-may augment the effects of antidepressants & antianxiety meds

-can be dosed at bedtime if fatigue is noted

-unlikely to worsen tics

Non-stimulant medication: Clonidine .....ANSWER.....-α 2 agonist

• May be taken as monotherapy or with stimulant medications

-enhances precortical function for better mental focus

-appetite neutral

-may help with sleep disturbances, administer at bedtime

-adverse effects:

• sedation, brain fog

-monitor of BP closely during initial titration, risk of hypotension

-tapered to avoid rebound hypertension post discontinuation

Non-stimulant medication: guanfacine .....ANSWER.....-α 2 agonist

• May be taken as monotherapy or with stimulant medications